Prognostic role of METTL1 in glioma

BACKGROUND: Current treatment options for glioma are limited, and the prognosis of patients with glioma is poor as the available drugs show low therapeutic efficacy. Furthermore, the molecular mechanisms associated with glioma remain poorly understood. METTL1 mainly catalyzes the formation of N(7)-m...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Lun, Yang, Yi, Wang, Zhenshuang, Xu, Chengran, Huang, Jinhai, Li, Guangyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Primary Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8627054/
https://www.ncbi.nlm.nih.gov/pubmed/34838021
http://dx.doi.org/10.1186/s12935-021-02346-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8627054/
https://www.ncbi.nlm.nih.gov/pubmed/34838021
http://dx.doi.org/10.1186/s12935-021-02346-4

Ejemplares similares